Pfizer sells research site to Monsanto for $435 million
This article was originally published in Scrip
Executive Summary
Pfizer has sold its Chesterfield Village Research Center to the agricultural products giant Monsanto for $435 million. Pfizer will continue to operate out of the Missouri site through a lease agreement. Its main focus will be biotherapeutic pharmaceutical research.